Cotecna, a Geneva, Switzerland-based provider of testing, inspection and certification services acquired Neotron, a global provider of testing services for food products, supplements, cosmetics and pharmaceutical products, based in Italy.
Neural Concept SA, a Lausanne, Switzerland-based provider of cloud-based simulation software dedicated to Computer Assisted Engineering and Design, raised a seven-digit funding round.
Pfizer (NYSE: PFE) is to acquire Therachon Holding AG, a Basel, Switzerland-based clinical-stage biotechnology company focused on rare diseases, with assets in development for the treatment of achondroplasia and short bowel syndrome (SBS), for up to $810m.
SamanTree Medical, a Lausanne, Switzerland-based cancer surgery company, closed a CHF 9.5m Series A financing.
RosieReality, a Zurich, Switzerland-based startup that leverages AR to let kids learn programming and robotics, raised $2.2M in seed funding.
Bond Mobility Inc., a Palo Alto, Calif.- and Zurich, Switzerland-based eBike sharing company that delivers high-performance micromobility services, closed $20m series A funding.
Alentis Therapeutics, a Basel, Switzerland – based biotech company developing novel therapeutics in advanced liver disease and cancer, closed a CHF 12.5m (€11.1m; USD12.5m) Series A financing.
Lyfegen HealthTech AG, a Basel, Switzerland-based a healthcare technology company, closed its seed financing round, raising a total of CHF750k.
HQ Equita, HQ Capital’s private equity direct investment arm, closed its fifth fund, HQ Equita V, with capital commitments totaling €308m.
GuestReady, a London, UK-based global short-term rental company, acquired BnbLord, an Airbnb management company in France.
Polyneuron Pharmaceuticals AG, a Basel, Switzerland-based developer of a new class of biodegradable glycopolymers for the treatment of autoimmune diseases, closed a CHF22.5m Series A financing.
NovaGo Therapeutics AG, a Zurich, Switzerland-based biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke, closed a Series A financing round of CHF 10m.
Pangea Blockchain Fund, a Lugano, Switzerland-based firm focused on transformative blockchain solutions, closed its seed fund, at $22m.
GT Gain Therapeutics SA, a Lugano, Switzerland-based preclinical stage biotech company, closed a €2.5M Series A financing.
btov Partners, a European venture capital firm, held the second closing its new Industrial Technologies Fund, at €80m.